Eczacıbaşı Monrol Nuclear Products is founded by Bozlu Holding in 1995 and has continued its activities in partnership with Eczacıbaşı Pharmaceuticals Manufacturing since 2008, while leading the development of nuclear medicine in Turkey since its establishment, is a nuclear medicine company that also carries out its expertise all around the world with high quality standarts of radiopharmaceuticals and logistics infrastructure produced with EU-GMP quality.
BINDS YOU TO LIFE
Eczacıbaşı- Monrol has signed production and distribution agreement with TELIX PHARMACEUTICALS
As Eczacıbaşı-Monrol, we will be the radiopharmeceutical production partner and the distributor in Turkey, and MENA region for Telix. Our initial focus will be on the production and distribution of TLX-CDx (Zr-89 girentuximab) for imaging of renal cell carcinoma with PET.